{"id":2024644,"date":"2026-07-03T09:35:13","date_gmt":"2026-07-03T06:35:13","guid":{"rendered":"https:\/\/analyse.optim.biz\/?p=2024644"},"modified":"2026-07-03T09:35:13","modified_gmt":"2026-07-03T06:35:13","slug":"asociatia-oncohelp-in-top-3-mondial-intr-un-studiu-clinic-international-dedicat-tratamentului-unei-boli-rare","status":"publish","type":"post","link":"https:\/\/analyse.optim.biz\/?p=2024644","title":{"rendered":"Asocia\u021bia OncoHelp, \u00een Top 3 mondial \u00eentr-un studiu clinic interna\u021bional dedicat tratamentului unei boli rare"},"content":{"rendered":"<p>[analyse_image type=&#8221;featured&#8221; src=&#8221;https:\/\/www.pressalert.ro\/wp-content\/uploads\/2026\/07\/Razvan-Onco.jpeghttps:\/\/www.pressalert.ro\/wp-content\/uploads\/2026\/07\/Razvan-Onco.jpeg&#8221;]<\/p>\n<article id=\"post-587737\" class=\"post-587737 post type-post status-publish format-standard has-post-thumbnail hentry category-editori category-stiri category-stiri-locale category-timis-stiri-locale tag-asociatia-oncohelp tag-centrul-oncohelp tag-intestinal tag-studiu tag-timis tag-timisoara tag-top-3-mondial\">\n<div class=\"td-post-header td-pb-padding-side\">\n<div class=\"entry-crumbs\"><span><a title class=\"entry-crumb\" href=\"https:\/\/www.pressalert.ro\/\"><span>Acas\u0103<\/span><\/a><\/span><span><a title=\"Vede\u021bi toate articolele \u00een Recomand\u0103rile editorilor\" class=\"entry-crumb\" href=\"https:\/\/www.pressalert.ro\/category\/editori\/\"><span>Recomand\u0103rile editorilor<\/span><\/a><\/span><span class=\"td-bred-no-url-last\">Asocia\u021bia OncoHelp, \u00een Top 3 mondial \u00eentr-un studiu clinic interna\u021bional dedicat tratamentului&#8230;<\/span><\/div>\n<ul class=\"td-category\">\n<li class=\"entry-category\"><a href=\"https:\/\/www.pressalert.ro\/category\/editori\/\">Recomand\u0103rile editorilor<\/a><\/li>\n<li class=\"entry-category\"><a href=\"https:\/\/www.pressalert.ro\/category\/stiri\/\">\u015etiri<\/a><\/li>\n<li class=\"entry-category\"><a href=\"https:\/\/www.pressalert.ro\/category\/stiri\/stiri-locale\/\">\u0218tiri locale<\/a><\/li>\n<li class=\"entry-category\"><a href=\"https:\/\/www.pressalert.ro\/category\/stiri\/stiri-locale\/timis-stiri-locale\/\">\u0218tiri Timi\u0219<\/a><\/li>\n<\/ul>\n<header>\n<h1 class=\"entry-title\">Asocia\u021bia OncoHelp, \u00een Top 3 mondial \u00eentr-un studiu clinic interna\u021bional dedicat tratamentului unei boli rare<\/h1>\n<div class=\"meta-info\">\n<div class=\"td-post-author-name\">\n<div class=\"td-author-by\">De<\/div>\n<p><a href=\"https:\/\/www.pressalert.ro\/author\/marius-popescu\/\">Marius Popescu<\/a><\/p>\n<div class=\"td-author-line\"> &#8211; <\/div>\n<\/div>\n<p><span class=\"td-post-date\"><time class=\"entry-date updated td-module-date\" datetime=\"2026-07-03T09:35:13+00:00\">iul. 3, 2026<\/time><\/span><\/p>\n<div class=\"td-post-comments\"><a href=\"https:\/\/www.pressalert.ro\/2026\/07\/asociatia-oncohelp-in-top-3-mondial-intr-un-studiu-clinic-international-dedicat-tratamentului-unei-boli-rare\/#respond\">0<\/a><\/div>\n<\/div>\n<\/header>\n<\/div>\n<div class=\"td-post-sharing td-post-sharing-top td-pb-padding-side\"><span class=\"td-post-share-title\">DISTRIBUI\u021aI<\/span><\/p>\n<div class=\"td-default-sharing \"><a class=\"td-social-sharing-buttons td-social-facebook\" href=\"https:\/\/www.facebook.com\/sharer.php?u=https%3A%2F%2Fwww.pressalert.ro%2F2026%2F07%2Fasociatia-oncohelp-in-top-3-mondial-intr-un-studiu-clinic-international-dedicat-tratamentului-unei-boli-rare%2F\"><\/p>\n<div class=\"td-social-but-text\">Facebook<\/div>\n<p><\/a><a class=\"td-social-sharing-buttons td-social-twitter\" href=\"https:\/\/twitter.com\/intent\/tweet?text=Asocia%C8%9Bia+OncoHelp%2C+%C3%AEn+Top+3+mondial+%C3%AEntr-un+studiu+clinic+interna%C8%9Bional+dedicat+tratamentului+unei+boli+rare&amp;url=https%3A%2F%2Fwww.pressalert.ro%2F2026%2F07%2Fasociatia-oncohelp-in-top-3-mondial-intr-un-studiu-clinic-international-dedicat-tratamentului-unei-boli-rare%2F&amp;via=PRESSALERT.ro\"><\/p>\n<div class=\"td-social-but-text\">Twitter<\/div>\n<p><\/a><\/div>\n<\/div>\n<div class=\"td-post-content td-pb-padding-side\">\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"576\" height=\"768\" src=\"https:\/\/www.pressalert.ro\/wp-content\/uploads\/2026\/07\/Razvan-Onco-576x768.jpeg\" alt class=\"wp-image-587740\"><\/figure>\n<\/div>\n<p>Asocia\u021bia OncoHelp \u2013 Centrul de Oncologie OncoHelp, se claseaz\u0103 \u00een top 3 mondial al unui studiu clinic pentru tratamentul unei boli inflamatorii intestinale. E vorba despre o form\u0103 moderat sever\u0103 de rectocolit\u0103 ulcero-hemoragic\u0103.<\/p>\n<p>Asocia\u021bia OncoHelp este acreditat\u0103 la nivel european pentru derularea studiilor clinice \u00een gastroenterologie.<\/p>\n<p>Programul clinic se adreseaz\u0103 pacien\u021bilor cu o form\u0103 moderat sever\u0103 de rectocolit\u0103 ulcero-hemoragic\u0103. Aceasta este o boal\u0103 inflamatorie cronic\u0103 a intestinului care afecteaz\u0103 mucoasa colonului \u0219i a rectului. Face parte din grupul bolilor inflamatorii intestinale, al\u0103turi de boala Crohn. \u00cen cazul acestei afec\u021biuni, sistemul imunitar reac\u021bioneaz\u0103 anormal \u0219i produce o inflama\u021bie persistent\u0103 la nivelul intestinului gros.<\/p>\n<p>Studiul clinic interna\u021bional se desf\u0103\u0219oar\u0103 \u00een 270 de centre medicale din \u00eentreaga lume \u0219i a inclus p\u00e2n\u0103 \u00een prezent 573 de pacien\u021bi. Asocia\u021bia OncoHelp ocup\u0103 locul al treilea la nivel mondial \u00een clasamentul centrelor care au inclus cei mai mul\u021bi pacien\u021bi \u00een programul de cercetare \u0219i primul loc \u00een Rom\u00e2nia.<\/p>\n<p>Prima etap\u0103 a acestui studiu, implementat \u00een Compartimentul de Gastroenterologie din cadrul Asocia\u021biei OncoHelp, a presupus identificarea \u0219i evaluarea pacien\u021bilor eligibili pentru includerea \u00een programul interna\u021bional.<\/p>\n<p>\u201eAu fost selecta\u021bi pacien\u021bii cu forme moderat severe, care nu au r\u0103spuns la terapiile conven\u021bionale.<\/p>\n<p> Studiul \u00een care ace\u0219tia au fost inclu\u0219i a fost unul de tip head-to-head. Cu alte cuvinte, \u00een loc s\u0103 se compare un medicament nou cu placebo sau cu lipsa tratamentului, noi compar\u0103m tratamentul nou cu tratamentul standard existent pentru a vedea care este mai eficient. \u00cen acest caz, programul clinic presupune administrarea unor molecule biologice de ultim\u0103 genera\u021bie. Pentru pacien\u021bi, includerea \u00eentr-un astfel de program \u00eenseamn\u0103 nu doar controlul simptomelor, ci \u0219i posibilitatea ca, \u00een urma administr\u0103rii terapiei, afec\u021biunea s\u0103 intre \u00een remisie\u201d, a spus dr. R\u0103zvan Diaconescu, medic primar gastroenterolog, Asocia\u021bia OncoHelp \u2013 Centrul de Oncologie OncoHelp Timi\u0219oara.<\/p>\n<p>Astfel de studii, organizate la nivel mondial \u0219i coordonate de echipe interna\u021bionale, dau posibilitatea utiliz\u0103rii unor terapii biologice de ultim\u0103 genera\u021bie, inclusiv agen\u021bi monoclonali, care pot duce la reducerea inflama\u021biei \u0219i la controlul bolii.<\/p>\n<p>\u201eSuntem la trei luni de la ini\u021bierea tratamentului, iar rezultatele de p\u00e2n\u0103 acum sunt foarte bune. Am trecut de la tratamentul intravenos la administrarea unui tratament subcutanat. Asta \u00eenseamn\u0103 o injec\u021bie la fiecare dou\u0103 luni. Este un \u00eenceput extrem de promi\u021b\u0103tor, pentru c\u0103 vorbim despre pacien\u021bi care nu au r\u0103spuns la tratamentele anterioare. Medica\u021bia este atent selectat\u0103, adaptat\u0103 fiec\u0103rui pacient \u00een parte, iar monitorizarea este strict\u0103, de la primele administr\u0103ri p\u00e2n\u0103 la finalul protocolului de studiu. Boala despre care vorbim, rectocolita ulcero-hemoragic\u0103, poate ap\u0103rea la orice v\u00e2rst\u0103, \u00eens\u0103 este diagnosticat\u0103 cel mai frecvent \u00eentre 15 \u0219i 35 de ani, deci \u00een perioada activ\u0103 a unei persoane. \u00cen plus, de\u0219i deocamdat\u0103 nu exist\u0103 un tratament care s\u0103 vindece definitiv boala, exist\u0103 terapii care pot controla inflama\u021bia \u0219i pot men\u021bine perioade lungi de remisiune. De aceea, orice terapie biologic\u0103 nou\u0103 reprezint\u0103 un pas important \u00eenainte \u00een tratamentul acestei afec\u021biuni\u201d, a ad\u0103ugat dr. R\u0103zvan Diaconescu, medic primar gastroenterolog, Asocia\u021bia OncoHelp \u2013 Centrul de Oncologie OncoHelp Timi\u0219oara.<\/p>\n<p>Asocia\u021bia OncoHelp \u2013 Centrul de Oncologie OncoHelp este centru acreditat european pentru studii clinice \u00een cazul bolilor inflamatorii gastrointestinale.<\/p>\n<\/div>\n<footer>\n<div class=\"td-post-source-tags td-pb-padding-side\">\n<ul class=\"td-tags td-post-small-box clearfix\">\n<li><span>ETICHETE<\/span><\/li>\n<li><a href=\"https:\/\/www.pressalert.ro\/tag\/asociatia-oncohelp\/\">asociatia oncohelp<\/a><\/li>\n<li><a href=\"https:\/\/www.pressalert.ro\/tag\/centrul-oncohelp\/\">centrul oncohelp<\/a><\/li>\n<li><a href=\"https:\/\/www.pressalert.ro\/tag\/intestinal\/\">intestinal<\/a><\/li>\n<li><a href=\"https:\/\/www.pressalert.ro\/tag\/studiu\/\">studiu<\/a><\/li>\n<li><a href=\"https:\/\/www.pressalert.ro\/tag\/timis\/\">timis<\/a><\/li>\n<li><a href=\"https:\/\/www.pressalert.ro\/tag\/timisoara\/\">Timisoara<\/a><\/li>\n<li><a href=\"https:\/\/www.pressalert.ro\/tag\/top-3-mondial\/\">top 3 mondial<\/a><\/li>\n<\/ul>\n<\/div>\n<div class=\"td-post-sharing td-post-sharing-bottom td-pb-padding-side\"><span class=\"td-post-share-title\">DISTRIBUI\u021aI<\/span><\/p>\n<div class=\"td-default-sharing \"><a class=\"td-social-sharing-buttons td-social-facebook\" href=\"https:\/\/www.facebook.com\/sharer.php?u=https%3A%2F%2Fwww.pressalert.ro%2F2026%2F07%2Fasociatia-oncohelp-in-top-3-mondial-intr-un-studiu-clinic-international-dedicat-tratamentului-unei-boli-rare%2F\"><\/p>\n<div class=\"td-social-but-text\">Facebook<\/div>\n<p><\/a><a class=\"td-social-sharing-buttons td-social-twitter\" href=\"https:\/\/twitter.com\/intent\/tweet?text=Asocia%C8%9Bia+OncoHelp%2C+%C3%AEn+Top+3+mondial+%C3%AEntr-un+studiu+clinic+interna%C8%9Bional+dedicat+tratamentului+unei+boli+rare&amp;url=https%3A%2F%2Fwww.pressalert.ro%2F2026%2F07%2Fasociatia-oncohelp-in-top-3-mondial-intr-un-studiu-clinic-international-dedicat-tratamentului-unei-boli-rare%2F&amp;via=PRESSALERT.ro\"><\/p>\n<div class=\"td-social-but-text\">Twitter<\/div>\n<p><\/a><\/div>\n<\/div>\n<div class=\"td-block-row td-post-next-prev\">\n<div class=\"td-block-span6 td-post-prev-post\">\n<div class=\"td-post-next-prev-content\"><span>Articolul precedent<\/span><a href=\"https:\/\/www.pressalert.ro\/2026\/07\/seceta-si-temperaturi-mai-ridicate-in-vestul-tarii-prognoza-meteo-pentru-urmatoarele-patru-saptamani\/\">Secet\u0103 \u0219i temperaturi mai ridicate \u00een vestul \u021b\u0103rii. Prognoza meteo pentru urm\u0103toarele patru s\u0103pt\u0103m\u00e2ni<\/a><\/div>\n<\/div>\n<div class=\"td-block-span6 td-post-next-post\">\n<div class=\"td-post-next-prev-content\"><span>Articolul urm\u0103tor<\/span><a href=\"https:\/\/www.pressalert.ro\/2026\/07\/erlend-krauser-sustinut-un-concert-memorabil-la-timisoara-video\/\">Erlend Krauser a sus\u021binut un concert memorabil la Timi\u0219oara (video)<\/a><\/div>\n<\/div>\n<\/div>\n<div class=\"author-box-wrap\"><a href=\"https:\/\/www.pressalert.ro\/author\/marius-popescu\/\"><img loading=\"lazy\" decoding=\"async\" alt src=\"https:\/\/secure.gravatar.com\/avatar\/6ff5b29455ffa79f6eac9c7ee3cb2891?s=96&amp;d=mm&amp;r=g\" class=\"avatar avatar-96 photo\" height=\"96\" width=\"96\"><\/a><\/p>\n<div class=\"desc\">\n<div class=\"td-author-name vcard author\"><span class=\"fn\"><a href=\"https:\/\/www.pressalert.ro\/author\/marius-popescu\/\">Marius Popescu<\/a><\/span><\/div>\n<div class=\"td-author-url\"><a href=\"https:\/\/www.pressalert.ro\">http:\/\/www.pressalert.ro<\/a><\/div>\n<\/div>\n<\/div>\n<p><span><\/span><span><span><\/span><\/span><span><\/span><\/footer>\n<\/article>\n<div class=\"td-post-content td-pb-padding-side\">\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"576\" height=\"768\" src=\"https:\/\/www.pressalert.ro\/wp-content\/uploads\/2026\/07\/Razvan-Onco-576x768.jpeg\" alt class=\"wp-image-587740\"><\/figure>\n<\/div>\n<p>Asocia\u021bia OncoHelp \u2013 Centrul de Oncologie OncoHelp, se claseaz\u0103 \u00een top 3 mondial al unui studiu clinic pentru tratamentul unei boli inflamatorii intestinale. E vorba despre o form\u0103 moderat sever\u0103 de rectocolit\u0103 ulcero-hemoragic\u0103.<\/p>\n<p>Asocia\u021bia OncoHelp este acreditat\u0103 la nivel european pentru derularea studiilor clinice \u00een gastroenterologie.<\/p>\n<p>Programul clinic se adreseaz\u0103 pacien\u021bilor cu o form\u0103 moderat sever\u0103 de rectocolit\u0103 ulcero-hemoragic\u0103. Aceasta este o boal\u0103 inflamatorie cronic\u0103 a intestinului care afecteaz\u0103 mucoasa colonului \u0219i a rectului. Face parte din grupul bolilor inflamatorii intestinale, al\u0103turi de boala Crohn. \u00cen cazul acestei afec\u021biuni, sistemul imunitar reac\u021bioneaz\u0103 anormal \u0219i produce o inflama\u021bie persistent\u0103 la nivelul intestinului gros.<\/p>\n<p>Studiul clinic interna\u021bional se desf\u0103\u0219oar\u0103 \u00een 270 de centre medicale din \u00eentreaga lume \u0219i a inclus p\u00e2n\u0103 \u00een prezent 573 de pacien\u021bi. Asocia\u021bia OncoHelp ocup\u0103 locul al treilea la nivel mondial \u00een clasamentul centrelor care au inclus cei mai mul\u021bi pacien\u021bi \u00een programul de cercetare \u0219i primul loc \u00een Rom\u00e2nia.<\/p>\n<p>Prima etap\u0103 a acestui studiu, implementat \u00een Compartimentul de Gastroenterologie din cadrul Asocia\u021biei OncoHelp, a presupus identificarea \u0219i evaluarea pacien\u021bilor eligibili pentru includerea \u00een programul interna\u021bional.<\/p>\n<p>\u201eAu fost selecta\u021bi pacien\u021bii cu forme moderat severe, care nu au r\u0103spuns la terapiile conven\u021bionale.<\/p>\n<p> Studiul \u00een care ace\u0219tia au fost inclu\u0219i a fost unul de tip head-to-head. Cu alte cuvinte, \u00een loc s\u0103 se compare un medicament nou cu placebo sau cu lipsa tratamentului, noi compar\u0103m tratamentul nou cu tratamentul standard existent pentru a vedea care este mai eficient. \u00cen acest caz, programul clinic presupune administrarea unor molecule biologice de ultim\u0103 genera\u021bie. Pentru pacien\u021bi, includerea \u00eentr-un astfel de program \u00eenseamn\u0103 nu doar controlul simptomelor, ci \u0219i posibilitatea ca, \u00een urma administr\u0103rii terapiei, afec\u021biunea s\u0103 intre \u00een remisie\u201d, a spus dr. R\u0103zvan Diaconescu, medic primar gastroenterolog, Asocia\u021bia OncoHelp \u2013 Centrul de Oncologie OncoHelp Timi\u0219oara.<\/p>\n<p>Astfel de studii, organizate la nivel mondial \u0219i coordonate de echipe interna\u021bionale, dau posibilitatea utiliz\u0103rii unor terapii biologice de ultim\u0103 genera\u021bie, inclusiv agen\u021bi monoclonali, care pot duce la reducerea inflama\u021biei \u0219i la controlul bolii.<\/p>\n<p>\u201eSuntem la trei luni de la ini\u021bierea tratamentului, iar rezultatele de p\u00e2n\u0103 acum sunt foarte bune. Am trecut de la tratamentul intravenos la administrarea unui tratament subcutanat. Asta \u00eenseamn\u0103 o injec\u021bie la fiecare dou\u0103 luni. Este un \u00eenceput extrem de promi\u021b\u0103tor, pentru c\u0103 vorbim despre pacien\u021bi care nu au r\u0103spuns la tratamentele anterioare. Medica\u021bia este atent selectat\u0103, adaptat\u0103 fiec\u0103rui pacient \u00een parte, iar monitorizarea este strict\u0103, de la primele administr\u0103ri p\u00e2n\u0103 la finalul protocolului de studiu. Boala despre care vorbim, rectocolita ulcero-hemoragic\u0103, poate ap\u0103rea la orice v\u00e2rst\u0103, \u00eens\u0103 este diagnosticat\u0103 cel mai frecvent \u00eentre 15 \u0219i 35 de ani, deci \u00een perioada activ\u0103 a unei persoane. \u00cen plus, de\u0219i deocamdat\u0103 nu exist\u0103 un tratament care s\u0103 vindece definitiv boala, exist\u0103 terapii care pot controla inflama\u021bia \u0219i pot men\u021bine perioade lungi de remisiune. De aceea, orice terapie biologic\u0103 nou\u0103 reprezint\u0103 un pas important \u00eenainte \u00een tratamentul acestei afec\u021biuni\u201d, a ad\u0103ugat dr. R\u0103zvan Diaconescu, medic primar gastroenterolog, Asocia\u021bia OncoHelp \u2013 Centrul de Oncologie OncoHelp Timi\u0219oara.<\/p>\n<p>Asocia\u021bia OncoHelp \u2013 Centrul de Oncologie OncoHelp este centru acreditat european pentru studii clinice \u00een cazul bolilor inflamatorii gastrointestinale.<\/p>\n<\/div>\n<p>[analyse_source url=&#8221;https:\/\/www.pressalert.ro\/2026\/07\/asociatia-oncohelp-in-top-3-mondial-intr-un-studiu-clinic-international-dedicat-tratamentului-unei-boli-rare\/&#8221;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[analyse_image type=&#8221;featured&#8221; src=&#8221;https:\/\/www.pressalert.ro\/wp-content\/uploads\/2026\/07\/Razvan-Onco.jpeghttps:\/\/www.pressalert.ro\/wp-content\/uploads\/2026\/07\/Razvan-Onco.jpeg&#8221;] Acas\u0103Recomand\u0103rile editorilorAsocia\u021bia OncoHelp, \u00een Top 3 mondial \u00eentr-un studiu clinic interna\u021bional dedicat tratamentului&#8230; Recomand\u0103rile editorilor \u015etiri \u0218tiri locale \u0218tiri Timi\u0219 Asocia\u021bia OncoHelp, \u00een Top 3 mondial \u00eentr-un studiu clinic interna\u021bional dedicat tratamentului unei boli rare De Marius Popescu &#8211; iul. 3, 2026 0 DISTRIBUI\u021aI Facebook Twitter Asocia\u021bia OncoHelp \u2013 Centrul de Oncologie [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[89],"tags":[226,176],"class_list":["post-2024644","post","type-post","status-publish","format-standard","hentry","category-romania","tag-crawlmanager","tag-pressalert-ro"],"_links":{"self":[{"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/posts\/2024644","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2024644"}],"version-history":[{"count":0,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/posts\/2024644\/revisions"}],"wp:attachment":[{"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2024644"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2024644"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2024644"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}